173 related articles for article (PubMed ID: 19426770)
1. Transcutaneous immunization using common chemicals.
Karande P; Arora A; Pham TK; Stevens D; Wojicki A; Mitragotri S
J Control Release; 2009 Sep; 138(2):134-40. PubMed ID: 19426770
[TBL] [Abstract][Full Text] [Related]
2. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
3. Development of novel fusogenic vesosomes for transcutaneous immunization.
Mishra V; Mahor S; Rawat A; Dubey P; Gupta PN; Singh P; Vyas SP
Vaccine; 2006 Jul; 24(27-28):5559-70. PubMed ID: 16730102
[TBL] [Abstract][Full Text] [Related]
4. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
[TBL] [Abstract][Full Text] [Related]
5. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.
Bal SM; Slütter B; Jiskoot W; Bouwstra JA
Vaccine; 2011 May; 29(23):4025-32. PubMed ID: 21443959
[TBL] [Abstract][Full Text] [Related]
6. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
Tezel A; Paliwal S; Shen Z; Mitragotri S
Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
[TBL] [Abstract][Full Text] [Related]
7. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
[TBL] [Abstract][Full Text] [Related]
9. Mannosylated niosomes as carrier adjuvant system for topical immunization.
Jain S; Vyas SP
J Pharm Pharmacol; 2005 Sep; 57(9):1177-84. PubMed ID: 16105238
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.
Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP
Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.
Hammond SA; Guebre-Xabier M; Yu J; Glenn GM
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):503-26. PubMed ID: 11763499
[TBL] [Abstract][Full Text] [Related]
13. Archaeosomes with encapsulated antigens for oral vaccine delivery.
Li Z; Zhang L; Sun W; Ding Q; Hou Y; Xu Y
Vaccine; 2011 Jul; 29(32):5260-6. PubMed ID: 21609747
[TBL] [Abstract][Full Text] [Related]
14. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
15. Tetanus toxoid-loaded transfersomes for topical immunization.
Gupta PN; Mishra V; Singh P; Rawat A; Dubey P; Mahor S; Vyas SP
J Pharm Pharmacol; 2005 Mar; 57(3):295-301. PubMed ID: 15807984
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies.
Karande P; Mitragotri S
Annu Rev Chem Biomol Eng; 2010; 1():175-201. PubMed ID: 22432578
[TBL] [Abstract][Full Text] [Related]
18. Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.
Miles AP; McClellan HA; Rausch KM; Zhu D; Whitmore MD; Singh S; Martin LB; Wu Y; Giersing BK; Stowers AW; Long CA; Saul A
Vaccine; 2005 Mar; 23(19):2530-9. PubMed ID: 15752840
[TBL] [Abstract][Full Text] [Related]
19. Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo.
Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
Int J Nanomedicine; 2011; 6():3241-50. PubMed ID: 22228992
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine.
Johnston D; Bystryn JC
Vaccine; 2006 Mar; 24(11):1958-65. PubMed ID: 16310898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
